Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 26 of 39

  1. Quick-Acting Heart Reliever

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Stenosis

    approved small molecule completed

    1 trial

  2. Qvar

    Teva Pharma GmbH

    Asthma

    approved small molecule terminated

    2 trials

  3. Qvar® (beclometasone dipropionate HFA)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  4. R0126321A

    Disc Medicine

    Diabetic foot ulcer

    approved small molecule active

    1 trial

  5. R668-AS-2373

    Lacuna Pharma Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  6. RADAR-1 CRPC

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial

  7. RAMIPRIL HOE498

    Sanofi Pasteur

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  8. RC-P0055

    The George Institute

    Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments.

    approved small molecule active

    1 trial

  9. RC-P0103

    The George Institute

    lumbosacral radiculalgia

    approved small molecule active

    1 trial

  10. RDD to Palynziq

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved small molecule active

    1 trial

  11. REPLAGAL

    Takeda

    Fabry Disease

    approved small molecule active

    5 trials

  12. RES-6128-C1

    Lacuna Pharma Pty Ltd

    Severe vitamin D deficiency

    approved small molecule active

    1 trial

  13. RF Ablation procedure

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    approved other completed

    1 trial

  14. RIBOCICLIB, Kisqali 200 mg film-coated tablets

    The George Institute

    Hormone receptor–positive (HRpos)/human epidermal growth factor receptor 2–negative (HER2neg) early breast cancer at risk of recurrence

    approved small molecule active

    1 trial

  15. RIMEGEPANT , Capsaicin

    Disc Medicine

    Obesity, Migraine

    approved small molecule active

    1 trial

  16. RIXUBIS: On-Demand

    Takeda

    Hemophilia B

    approved mab completed

    1 trial

  17. ROCTAVIAN 2 × 1013 vector genomes/mL solution for infusion

    BioMarin Pharmaceutical Australia Pty Ltd

    Hemophilia A

    approved small molecule active

    1 trial

  18. ROP

    GlaxoSmithKline

    Parkinson Disease

    approved small molecule completed

    1 trial

  19. ROPIDOL

    The George Institute

    lumbar arthrodesis

    approved small molecule active

    1 trial

  20. ROPIVACAINE , SODIUM CHLORIDE

    Disc Medicine

    Urolithiasis

    approved small molecule active

    1 trial

  21. ROSUVASTATIN for CHRONIC INFLAMMATORY RHEUMATIC…

    The George Institute

    CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoriatic arthritis or axial spondyloarthritis or systemic lupus erythematosus

    approved small molecule active

    1 trial

  22. RYMPHYSIA

    Takeda

    Chronic Obstructive Pulmonary Disease (COPD)

    approved mab terminated

    1 trial

  23. Rabbit ATG, (Genzyme)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aplastic Anemia

    approved small molecule active

    1 trial

  24. Rabipur Pulver und Lösungsmittel zur Herstell...

    The George Institute

    rabies pre-exposure prophylaxis

    approved small molecule active

    1 trial

  25. Rabipur for health volunteerst

    Disc Medicine

    health volunteerst

    approved small molecule active

    1 trial

  26. Radio-Flu 0 for Transthyretin amyloid cardiomyopathy

    Disc Medicine

    Transthyretin amyloid cardiomyopathy

    approved small molecule active

    1 trial

  27. Raltegravir

    Merck KGaA, Darmstadt, Germany

    Human Immunodeficiency Virus (HIV) Infection

    approved small molecule completed

    1 trial

  28. Raltitrexed

    The First People's Hospital of Lianyungang

    Head and Neck Squamous Cell Carcinoma

    approved small molecule active

    1 trial

  29. Ramelteon

    Takeda

    Seasonal Affective Disorder

    approved small molecule completed

    1 trial

  30. Ramelteon

    Takeda

    Insomnia

    approved small molecule completed

    6 trials

  31. Ramelteon

    Takeda

    ADHD With Sleep Onset Insomnia

    approved small molecule completed

    1 trial

  32. Ramelteon

    Takeda

    Bipolar Disorder

    approved small molecule terminated

    2 trials

  33. Ramelteon

    Takeda

    Chronic Insomnia

    approved small molecule completed

    7 trials

  34. Ramelteon

    Takeda

    Circadian Dysregulation

    approved small molecule completed

    1 trial

  35. Ramelteon

    Takeda

    Schizophrenia

    approved small molecule completed

    1 trial

  36. Ramelteon (RozeremR)

    Takeda

    Insomnia

    approved small molecule terminated

    1 trial

  37. Ramelteon and Placebo

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved small molecule completed

    2 trials

  38. Ramelteon and zolpidem

    Takeda

    Chronic Insomnia

    approved small molecule completed

    1 trial

  39. Ramelteon, zolpidem and placebo

    Takeda

    Insomnia

    approved small molecule completed

    1 trial

  40. Ramosetron

    Astellas Pharma Inc

    Irritable Bowel Syndrome

    approved small molecule completed

    1 trial

  41. Rapid Acting insulin with pre-treatment of rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  42. Rapydan

    Jazz Pharmaceuticals Ireland Limited

    Healthy

    approved small molecule terminated

    1 trial

  43. Rasagiline

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule active

    5 trials

  44. Rasagiline

    Teva Pharma GmbH

    Depressive Symptoms

    approved small molecule completed

    1 trial

  45. Rasagiline

    Teva Pharma GmbH

    Sleep Disturbances

    approved small molecule completed

    1 trial

  46. Rasagiline Mesylate

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    8 trials

  47. Rasagiline/Placebo

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    1 trial

  48. Re-JIA

    Istituto Gentili S.r.l.

    Juvenile idiopathic arthritis

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.